As Cigna (CI) Valuation Rose, Bank Of Stockton Has Increased Position; Thermo Fisher Scientific (TMO) Holder Papp L Roy & Associates Boosted Its Position by $329,049 as Share Value Rose

January 13, 2018 - By Richard Conner

Papp L Roy & Associates increased its stake in Thermo Fisher Scientific Inc (TMO) by 2.97% based on its latest 2017Q3 regulatory filing with the SEC. Papp L Roy & Associates bought 1,741 shares as the company’s stock rose 8.13% with the market. The institutional investor held 60,391 shares of the industrial machinery and components company at the end of 2017Q3, valued at $11.43 million, up from 58,650 at the end of the previous reported quarter. Papp L Roy & Associates who had been investing in Thermo Fisher Scientific Inc for a number of months, seems to be bullish on the $84.28B market cap company. The stock increased 0.72% or $1.51 during the last trading session, reaching $210.17. About 1.49 million shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 15.57% since January 13, 2017 and is uptrending. It has underperformed by 1.13% the S&P500.

Bank Of Stockton increased its stake in Cigna Corporation (CI) by 42.77% based on its latest 2017Q3 regulatory filing with the SEC. Bank Of Stockton bought 2,363 shares as the company’s stock rose 11.09% with the market. The institutional investor held 7,888 shares of the medical specialities company at the end of 2017Q3, valued at $1.47M, up from 5,525 at the end of the previous reported quarter. Bank Of Stockton who had been investing in Cigna Corporation for a number of months, seems to be bullish on the $52.61 billion market cap company. The stock increased 1.19% or $2.5 during the last trading session, reaching $213.39. About 1.15 million shares traded. Cigna Corporation (NYSE:CI) has risen 23.57% since January 13, 2017 and is uptrending. It has outperformed by 6.87% the S&P500.

Papp L Roy & Associates, which manages about $782.06 million and $462.54 million US Long portfolio, decreased its stake in Parexel Intl Corp (NASDAQ:PRXL) by 21,382 shares to 6,950 shares, valued at $612,000 in 2017Q3, according to the filing. It also reduced its holding in Factset Resh Sys Inc (NYSE:FDS) by 2,542 shares in the quarter, leaving it with 31,876 shares, and cut its stake in Alphabet Inc.

Since August 2, 2017, it had 0 buys, and 7 selling transactions for $18.71 million activity. On Monday, August 28 the insider HOOGASIAN SETH H sold $736,092. Shine Daniel P also sold $366,645 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday, August 30. Another trade for 50,000 shares valued at $9.59 million was sold by CASPER MARC N. Another trade for 11,318 shares valued at $1.96M was made by MANZI JIM P on Thursday, August 17. Another trade for 3,894 shares valued at $721,091 was sold by HORNSTRA PETER E. On Wednesday, August 2 Herrema Gregory J. sold $5.28 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO) or 30,000 shares.

Among 18 analysts covering Thermo Fisher Scientific (NYSE:TMO), 17 have Buy rating, 0 Sell and 1 Hold. Therefore 94% are positive. Thermo Fisher Scientific had 53 analyst reports since July 24, 2015 according to SRatingsIntel. The company was initiated on Thursday, September 22 by JP Morgan. The firm has “Buy” rating given on Friday, September 8 by Cowen & Co. Cleveland upgraded Thermo Fisher Scientific Inc. (NYSE:TMO) on Thursday, July 20 to “Buy” rating. The firm earned “Neutral” rating on Friday, September 9 by Cleveland. The stock has “Hold” rating by Jefferies on Friday, April 29. Barclays Capital maintained it with “Buy” rating and $215.0 target in Monday, September 25 report. On Thursday, July 23 the stock rating was maintained by Mizuho with “Buy”. The rating was maintained by Jefferies with “Hold” on Thursday, March 30. On Friday, April 28 the stock rating was maintained by Leerink Swann with “Buy”. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Hold” rating given on Tuesday, August 22 by Jefferies.

Investors sentiment increased to 0.96 in Q3 2017. Its up 0.05, from 0.91 in 2017Q2. It improved, as 51 investors sold TMO shares while 383 reduced holdings. 77 funds opened positions while 339 raised stakes. 333.20 million shares or 3.09% more from 323.23 million shares in 2017Q2 were reported. Cullinan Associates Incorporated invested in 0.32% or 22,095 shares. Cypress Mngmt Limited Liability Company owns 1,350 shares. Green Valley Investors Limited Liability owns 187,206 shares. New York-based Morgan Stanley has invested 0.24% in Thermo Fisher Scientific Inc. (NYSE:TMO). Americafirst Cap Mgmt Limited Liability Corp holds 1.18% or 4,629 shares in its portfolio. Hl Ser Limited Liability holds 5,567 shares or 0.02% of its portfolio. Fiduciary Trust Comm owns 104,477 shares or 0.61% of their US portfolio. Dumont And Blake Advsrs Ltd Co has invested 0.44% in Thermo Fisher Scientific Inc. (NYSE:TMO). Hudson Valley Inv Advsr Adv has invested 2.09% in Thermo Fisher Scientific Inc. (NYSE:TMO). 18,675 were accumulated by Victory. Consulta Ltd accumulated 175,000 shares. Eagleclaw Cap Managment Ltd Liability Com stated it has 9,025 shares or 0.97% of all its holdings. Baldwin Inv Management Limited Liability Company reported 0.61% stake. Smithfield Tru holds 0.16% or 6,348 shares. Cim Mangement Incorporated reported 3,559 shares.

Among 19 analysts covering CIGNA (NYSE:CI), 15 have Buy rating, 0 Sell and 4 Hold. Therefore 79% are positive. CIGNA had 53 analyst reports since July 27, 2015 according to SRatingsIntel. UBS maintained Cigna Corporation (NYSE:CI) on Monday, June 5 with “Buy” rating. The stock of Cigna Corporation (NYSE:CI) has “Buy” rating given on Thursday, October 12 by RBC Capital Markets. Barclays Capital maintained the shares of CI in report on Wednesday, January 6 with “Equal-Weight” rating. The firm has “Buy” rating given on Thursday, July 13 by Cowen & Co. The company was maintained on Thursday, November 2 by Jefferies. The stock has “Buy” rating by RBC Capital Markets on Monday, August 7. The rating was maintained by RBC Capital Markets with “Buy” on Sunday, July 23. The stock of Cigna Corporation (NYSE:CI) has “Sector Perform” rating given on Tuesday, August 18 by RBC Capital Markets. The firm has “Hold” rating by Evercore given on Friday, September 23. Jefferies upgraded the shares of CI in report on Friday, January 8 to “Buy” rating.

Bank Of Stockton, which manages about $219.34M US Long portfolio, decreased its stake in Guggenheim S&P 500 Pure Value (RPV) by 11,140 shares to 227,496 shares, valued at $14.00 million in 2017Q3, according to the filing. It also reduced its holding in Guggenheim Midcap Pure Value (RFV) by 28,660 shares in the quarter, leaving it with 72,707 shares, and cut its stake in Guggenheim Midcap Pure Gr (RFG).

Investors sentiment is 0.96 in Q3 2017. Its the same as in 2017Q2. It is the same, as 47 investors sold CI shares while 249 reduced holdings. only 72 funds opened positions while 212 raised stakes. 206.32 million shares or 5.35% less from 217.98 million shares in 2017Q2 were reported. 10,369 are owned by Capital Fund Mngmt. Pennsylvania-based Jfs Wealth Limited Co has invested 0.01% in Cigna Corporation (NYSE:CI). Numeric Ltd Co reported 625,402 shares stake. Cibc Ww holds 0.07% or 38,756 shares in its portfolio. Citigroup holds 113,855 shares or 0.02% of its portfolio. Baystate Wealth Mgmt Ltd Liability stated it has 0.02% of its portfolio in Cigna Corporation (NYSE:CI). Meag Munich Ergo Kapitalanlagegesellschaft Mbh, Germany-based fund reported 41,021 shares. Pensionfund Dsm Netherlands owns 22,000 shares. Moreover, Wellington Gp Limited Liability Partnership has 0.39% invested in Cigna Corporation (NYSE:CI) for 9.12 million shares. Zwj Counsel Incorporated holds 0.03% or 2,318 shares. Benjamin F Edwards & Company Inc reported 600 shares. Rampart Invest Mngmt Limited Com accumulated 3,516 shares or 0.22% of the stock. Norinchukin National Bank & Trust The reported 18,740 shares. First Mercantile Trust Com owns 14,780 shares or 0.5% of their US portfolio. 331 were reported by Mcf Advsrs Ltd Liability.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>